CClinicalTrials.gg
RecruitingNCT07397234Updated Jul 28, 2026

Thyroid Cartilage Plane VS Superior Laryngeal Nerve Space Block in Awake Tracheal Intubation

An interventional study of Ultrasound-guided bilateral Thyroid Cartilage Plane Block and Ultrasound-guided bilateral Superior Laryngeal Nerve Space Block in Superior Laryngeal Nerve Block, sponsored by Nanjing First Hospital, Nanjing Medical University. Recruiting at 2 sites in China. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2026-07-28.

Sponsored by Nanjing First Hospital, Nanjing Medical University · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Started Feb 2026; still recruiting 7 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
94
Allocation
Randomized
Ages
18 Years to 85 Years
Sex
All
01

Study summary

The aim of this clinical trial is to compare the effectiveness and safety of ultrasound-guided thyroid cartilage plane approach with the superior laryngeal nerve space approach for superior laryngeal nerve block in awake tracheal intubation. Patients were randomized into the thyroid cartilage plane block group (T group) or the superior laryngeal nerve space block group (C group). In Group T, bilateral thyroid cartilage plane block was performed under ultrasound with thyroid cartilage as the landmark, and local anesthetic was injected on the surface of the thyroid cartilage. In Group C, local anesthetic was injected into the space between the thyrohyoid membrane and muscle groups above.

The investigators aim to evaluate whether the thyroid cartilage plane approach is not inferior to the superior laryngeal nerve space approach for ultrasound-guided superior laryngeal nerve block in awake tracheal intubation

Read the detailed description

After entering the operation room, ECG, SPO2, and invasive blood pressure were monitored. Sedation was facilitated. The proper anaesthesia depth was maintained at 60-80 using the bispectral index. Additionally, 0.5 mg of Penehyclidine Hydrochloride was injected intravenously once the venous access was established. 100% oxygen 4 L min-1 was administered with a nasal cannula throughout the procedure. All patients received topical pharyngeal anesthesia using lidocaine spray. The investigators used a 5-12 MHz linear probeto perform bilateral block. The probe was placed parasagittally to locate the thyroid cartilage and superior laryngeal nerve space. After identification of related structure, the investigators advanced a 22-gauge needle medial to the transducer at the upper half of the thyroid cartilage laminae until it touched the laminae or superior laryngeal nerve space using the out-of-plane technique. The correct location of the needle tip in the fascial deep to the muscle groups was confirmed by injecting 0.5-1 ml saline. A total of 2% lidocaine 2.5 ml was administered after negative aspiration bilaterally. "Spray-as-you-go" technique guided by a fiberoptic bronchoscope was performed to the tracheal with 5 ml of 2% lidocaine. After airway anesthesia, intubation completed.

The primary outcome was the proportion of acceptable intubation conditions (AIC). Secondary outcomes were the performance time, Ramsay sedation score, the patient's cough condition, comfort score, and tracheal tube tolerance score and other perioperative complications including airway hemorrhage and superior laryngeal nerve damage.

02

Conditions studied

  • Superior Laryngeal Nerve Block

Keywords

  • Thyroid Cartilage plane
  • Superior laryngeal nerve space
  • Difficult airway
  • Superior Laryngeal Nerve
  • Awake tracheal intubation
  • Nerve block
03

In context

Lead sponsor

Nanjing First Hospital, Nanjing Medical University is the lead sponsor of 213 studies on the registry; 106 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Patients scheduled for awake tracheal intubation under general anesthesia.
  2. Patients with difficult airways (e.g., limited cervical spine mobility, full stomach, partial airway obstruction, craniofacial deformities or trauma, micrognathia, mouth opening \<3cm, Mallampati III or IV classification) posing challenges for mask ventilation or intubation.
  3. Age between 18 and 85 years old.
  4. Gender is not restricted.
  5. ASA classification of I - III.

Exclusion criteria

Exclusion Criteria:

  1. Cardiovascular dysfunction or arterial aneurysms.
  2. Mental or neurological disorders or concomitant arterial aneurysms.
  3. Infection at the puncture site.
  4. Allergy to local anesthetics.
  5. Continuous use of antiplatelet or anticoagulant medications preoperatively.
  6. Hoarseness or coughing while drinking water.
  7. Bronchial asthma.
  8. Participation in other clinical trials within the previous 3 months before enrollment 9.r current participation in other clinical trials.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
94 participants (estimated)

Study arms

  • Active comparator
    Superior Laryngeal Nerve Space Block Group (C Group)

    All patients received topical oral and pharyngeal anesthesia using 2.4% lidocaine spray. The pharyngeal surface was sprayed twice, with each spray lasting one second, and repeated after a 5-minute interval. Under ultrasound guidance, the needle was advanced step by step into the potential space between the relevant muscle groups and the thyrohyoid membrane. When the needle tip contacted the surface of the thyrohyoid membrane and slightly penetrated the submembranous tissue, negative aspiration was confirmed, and 2.5 mL of 2% lidocaine was injected into the space on each side. Subsequently, performing fiberoptic bronchoscope-guided subglottis and tracheal surface topical anesthesia using 5ml of 2% lidocaine. After completing surface anesthesia, performing fiberoptic bronchoscope-guided tracheal intubation.

    Procedure: Ultrasound-guided bilateral Superior Laryngeal Nerve Space Block

  • Experimental
    Thyroid Cartilage Plane Block Group (T Group)

    All patients received topical oral and pharyngeal anesthesia using 2.4% lidocaine spray. The pharyngeal surface was sprayed twice, with each spray lasting one second, and repeated after a 5-minute interval. Ultrasound-guided bilateral Thyroid Cartilage Plane Block is performed using the thyroid cartilage as an anatomical landmark. 2.5ml of 2% lidocaine is injected on the surface of the thyroid cartilage each side. Subsequently, performing fiberoptic bronchoscope-guided subglottis and tracheal surface topical anesthesia using 2% lidocaine 5ml. After completing surface anesthesia, performing fiberoptic bronchoscope-guided tracheal intubation.

    Procedure: Ultrasound-guided bilateral Thyroid Cartilage Plane Block

Interventions

  • ProcedureUltrasound-guided bilateral Thyroid Cartilage Plane Block

    Use a SonoSite high-frequency linear array transducer (5-13 MHz, SonoSite, USA). Placing the transducer parallel to the spine on one side of the neck, ensuring clear visualization of the thyroid cartilage under ultrasound. Using the out-of-plane technique to visualize the needle insertion path and tip. Once the needle tip contacts the cranial half of the thyroid cartilage, injecting 2.5ml of 2% lidocaine on the surface of the thyroid cartilage each side.

  • ProcedureUltrasound-guided bilateral Superior Laryngeal Nerve Space Block

    Use a SonoSite high-frequency linear array transducer (5-13 MHz, SonoSite, USA). Placing the transducer parallel to the spine on one side of the neck, ensuring clear visualization of the superior laryngeal nerve space under ultrasound. Using the out-of-plane technique to visualize the needle insertion path and tip. 2% lidocaine 2.5ml was injected into the space between the thyrohyoid membrane and muscle groups above.

06

What researchers measure

Primary outcomes

  1. The proportion of patients with acceptable intubation conditions (AIC)

    The evaluation of the intubation condition was based on the Cormack-Lehane classification, vocal cord movement, 5-point reaction scale, and severity of coughing. Clinically, AIC was defined when each part was scaled to Grade 1 or Grade 2. The proportion of AIC = number of participants with AIC/number of participants who received ATI in each group.

    Time frame: Upon intubation

Secondary outcomes

  1. Quality of airway anesthesia

    The quality of airway anesthesia assessed on a 5-point scale,Quality of airwayanesthesia was graded as: 0=no coughing or gagging in response to intubation, 1=mild coughing and/or gaggingthat did not hinder intubation, 2=moderate coughing and/or gagging that interfered minimally with intubation,3=severe coughing and/or gagging that made intubation difficult and 4=very severe coughing and/or gaggingthat required additional local anesthetic and/or change in technique.The lower grade means a better quality of airway anesthesia.

    Time frame: Upon intubation

  2. Mean Arterial Pressure

    Stable blood pressure indicates a good neural blockade effect.

    Time frame: T0: upon entry to the operating room,T1: before insertion of the tracheal tube,T2: immediately after tracheal tube insertion,T3: 5 minutes after successful intubation

  3. Heart Rate

    Time Frame: T0: upon entry to the operating room,T1: before insertion of the tracheal tube,T2: immediatelyafter tracheal tube insertion,T3: 5 minutes after successful intubation

    Time frame: T0: upon entry to the operating room,T1: before insertion of the tracheal tube,T2: immediately after tracheal tube insertion,T3: 5 minutes after successful intubation

  4. Ramsay Sedation Score

    The Ramsay Sedation Score is as follows: 6 points for unarousable, 5 points for slow response to stimulus, 4points for asleep but easily aroused, 3 points for quiet and cooperative with orientation, 2 points for asleep,anxious, restless, and 1 point for asleep, agitated, and restless. Satisfactory sedation falls within 2-4 points,while oversedation is indicated by 5-6 points.

    Time frame: T0: upon entry to the operating room,T1: before insertion of the tracheal tube,T2: immediately after tracheal tube insertion,T3: 5 minutes after successful intubation

  5. The number of patients with lowered pitch

    A lowered pitch might indicate a good neural blockade effect.

    Time frame: Before intubation

  6. The time needed for blockade procedure

    The neural blockade procedure time reflects the ease of the operation, with a shorter time indicating a simpler neural blockade procedure.

    Time frame: From ultrasounography localization to completion of local anesthetic administration

  7. Record coughing in patients when the fiberoptic bronchoscope touches the glottis

    The patient's coughing upon contact of the fiberoptic bronchoscope with the vocal cords before intubation reflects the effectiveness of neural blockade. A lower degree of coughing indicates a better neural blockadeeffect. 1 point for no response, 2 points for mild cough, 3 points for severe cough.

    Time frame: Before intubation

  8. The tolerance score after the tube insertion

    The tolerance of the tube reflects the patient's tolerance to awake tracheal intubation. A higher score indicates a better outcome. 3 points for severe resistance requiring immediate general anesthesia, 2 points for restlessness and mild resistance, 1 point for cooperation.

    Time frame: Five minutes after successful intubation

  9. Adverse reactions such as coughing and nausea/vomiting

    The lower the incidence of coughing, nausea, and vomiting, the better the neural blockade effect.

    Time frame: During intubation

  10. Occurrences of sore throat and lowered pitch

    Pharyngeal pain and decreased vocal tone are used to assess postoperative complications of neural blockade.

    Time frame: Post-extubation,24 hours after surgery

  11. Total procedure time needed for awake intubation

    The total procedure time reflects the ease of the operation, with a shorter time indicating a simpler procedure.

    Time frame: From the initiation of topical anesthesia to the accomplishment of tracheal intubation

  12. Airway hemorrhage or nerve damage

    Observation of bleeding of the laryngeal mucosa via fiberoptic bronchoscope or observation of bloody secretions via coughing or suction

    Time frame: During intubation

07

Study locations

1 of 2 sites recruiting
  • Nanjing First Hospital
    Nanjing, Jiangsu 210006, China
    Completed
  • Nanjing First Hospital
    Nanjing, 210006, China
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 28, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07397234
Lead sponsor
Nanjing First Hospital, Nanjing Medical University
Responsible party
Tao Shan (Attending physician, Nanjing First Hospital, Nanjing Medical University) — Principal investigator
First posted
Feb 9, 2026
Start date
Feb 11, 2026
Primary completion
Sep 1, 2027 (estimated)
Completion
Sep 1, 2027 (estimated)
Last update
Jul 28, 2026

Study contacts

Tao Shan
Contact
858727933@qq.com
+8618852095135
Ying Zhang
Contact
1070434273@qq.com
+8615380998716
Tao Shan
principal investigator · Nanjing First Hospital, Nanjing Medical University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion